raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:70568

Post-transplant lymphoproliferative disease

Synonyms: PTLD

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A group of rare immunodeficiency-associated lymphoproliferative disorders characterized by lymphoid or plasmacytic proliferations developing in the context of immunosuppression in a recipient of a solid organ or stem cell allograft. The group includes non-destructive post-transplant lymphoproliferative disorders (PTLDs), polymorphic PTLD, monomorphic PTLDs, and classic Hodgkin lymphoma PTLD. Patients may have more than one type of PTLD in a single or in different locations. The most commonly involved sites are lymph nodes, gastrointestinal tract, lungs, and liver, although the disease may occur almost anywhere in the body. In solid organ transplant recipients, PTLD may also involve the allograft.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPost-transplant lymphoproliferative diseasePTLD
frMaladie lymphoproliférative post-tranplantation
deLymphoproliferative Erkrankung nach TransplantationPosttransplantations- Lymphoproliferativen Erkrankung (PTLD)
esEnfermedad linfoproliferativa post-trasplante
itMalattia linfoproliferativa post-trapianto
nlPost-transplantatie lymfoproliferatieve aandoening= en
ptDoença linfoproliferativa pós-transplanteDLPT
plPotransplantacyjna choroba limfoproliferacyjna= en
csPotransplantační lymfoproliferativní chorobaPTLCH
ukПосттрансплантаційне лімфопроліферативне захворювання= en
zh移植后淋巴增殖性疾病= en
trNakil sonrası lenfoproliferatif hastalık= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10D47.9NTBTattributedvalidated
MONDO0019088Evalidated
UMLSC0432487Evalidated
GARD9553Evalidated
MedDRA10051358Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-5 / 10 00026.2 / 100 000EuropeValue and classValidatedEuropean Medicines Agency[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

16 annotations · validated 2024-03-11
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0001608Abnormality of the voice
HP:0012378Fatigue
HP:0001945Fever
HP:0002716Lymphadenopathy
HP:0033834Malaise
HP:0030166Night sweats
HP:0033050Pharyngalgia
HP:0004396Poor appetite
HP:0025267Snoring
HP:0001824Weight loss
Occasional (29-5%)
HP:0002027Abdominal pain
HP:0002014Diarrhea
HP:0002239Gastrointestinal hemorrhage
HP:0012115Hepatitis
HP:0003073Hypoalbuminemia
HP:0033608Pulmonary nodule

Annotation source: 30020621[PMID]_37294957[PMID]_23802715[PMID]

7

Sources for this card